期刊文献+

产后甲状腺炎患者血清转化生长因子β_1的动态变化 被引量:1

Dynamic change of serum TGF-β_1 level in patients with postpartum thyroiditis
原文传递
导出
摘要 观察产后甲状腺炎(PPT)患者产后1年内血清转化生长因子β1(TGF-β1)的动态变化发现,PPT患者产后3、6和9个月时血清TGF-β1的水平较同月份对照产妇显著增加,提示TGF-β1参与了针对PPT自身免疫的整个拮抗过程。 A dynamic change of serum transforming growth factor-β1 (TGF-β1) level was observed in patients with postpartum thyroiditis (PPT) during the first postpartum year. TGF-β1 levels were higher in PPT patients at 3, 6 and 9 months of postpartum than those in control postpartum women, suggesting that TGF-β1 appears to be involved in the resistance to the PPT-related autoimmunity.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2006年第2期117-118,共2页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目(30370680) 辽宁省科技计划项目基金资助项目(2003225005) 辽宁省教育厅课题基金资助项目(202013158)
关键词 产后甲状腺炎 转化生长因子Β Postpartum thyroiditis Transforming growth factor-β
  • 相关文献

参考文献11

  • 1Mulier AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: Recent insights and consequences for antenatal and postnatal care. Endocrin Rev,2001,22:605-630.
  • 2Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 ( TGF-beta 1 ) in autoimmune diseases. J Autoimmun, 2000,14:23-42.
  • 3李晨阳,关海霞,李玉姝,范晨玲,欧阳煜宏,滕颖,丛琦,单忠艳,滕卫平.产后甲状腺炎的前瞻性临床流行病学调查[J].中华内分泌代谢杂志,2005,21(2):99-102. 被引量:62
  • 4Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature, 1992,359:693-699.
  • 5Toussirot EA. Oral tolerance in the treatment of rheumatoid arthritis. Curr Drug Targets Inflamm Allergy, 2002,1:45-52.
  • 6Widder J, Dorfinger K, Wilfing A, et al. The immunoregulatory influence of transforming growth factor beta in thyroid autoimmunity:TGF beta inhibits autoreactivity in Graves' disease. J Autoimmun,1991,4:689-701.
  • 7Guimaraes VC, Quintans J, Fisfalen ME, et al. Immunosuppression of thyroiditis. Endocrinology, 1996,137:2199-2207.
  • 8Kitani A, Chua K, Nakamura K, et al. Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J Immunol, 2000,165:691-702.
  • 9Chen W. TGFβ-released by apoptopic T cells contributes to an immunosuppressive milieu. Immunity, 2001,14:715-725.
  • 10Olivieri A, De Angelis S, Vaccari V, et al. Postpartum thyroiditis is associated with fluctuations in transforming growth factor-betal serum levels. J Clin Endocrinol Metab, 2003,88 : 1280-1284.

二级参考文献17

  • 1Larsen PR, Davies TF, Hay ID: In Wilson JD, et al (eds). Williams Textbook of Endocrinology. 9th ed, Philadelphia: WB Saunders, 2003,432.
  • 2Amino N, Tada H, Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid, 1999,9:705-713.
  • 3Roti E, Uberti E. Post-partum thyroiditis-a clinical update. Eur J Endocrinol, 2002,146:275-279.
  • 4Roberton HEW. Lassitude, coldness, and hair changes following pregnancy and their response to treatment with thyroid extract. Br Med J, 1948,93:2275-2276.
  • 5Amino N, Mori H, Iwatani Y, et al. High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N Engl J Med, 1982,306:849-852.
  • 6Stagnaro-Green A. Postpartum thyroiditis. Best Pract Res Clin Endocrinol Metab, 2004,18:303-316.
  • 7Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev, 2001,22:605-630.
  • 8McKenzie JM, Zakarija M. Antibodies in autoimmune thyroid disease. In: Braverman LE, Utiger R, eds. Werner and Ingbars the Thyroid. Philadelphia: Lippincott-Raven Publishers; 1996,416-432.
  • 9Hall R. Pregnancy and autoimmune endocrine disease. Baillieres Clin Endocrinol Metab, 1995,9:137-155.
  • 10Lazarus JH, Othman S. Thyroid disease in relation to pregnancy. Clin Endocrinol (Oxf), 1991,34:91-98.

共引文献61

同被引文献34

  • 1李贤厚,杜馥曼,杨善军,杨玉芝.Graves病患者外周血TGF-β_1的测定及临床意义[J].标记免疫分析与临床,2006,13(2):81-82. 被引量:1
  • 2Janssens K, ten Dijke P, Janssens S, et al. Transforming growth factor-beta 1 to the bone. Endocr Rev, 2005,26(6) : 743 -774.
  • 3Drugarin D, Negru S, Koreck A, et al. The pattern of a T (H) lcytokine in autoimmune thyroiditis. Immunol Lett, 2000,71 (2) :73-77.
  • 4ten Dijke P, Hill CS. New insights into TGF-beta-Smad signalling. Trends Bioehem Sei, 2004,29 ( 5 ) :265-273.
  • 5Yamada H, Watanabe M, Nanba T, et al. The + 869T/C polymorphism in the transforming growth factor-betal gene is associated with the severity and intractability of autoimmune thyroid disease. Clin Exp Immunol, 2008, 151 ( 3 ) : 379- 382.
  • 6Tada Y, Asahina A, Nakamura K, et al. Transforming growth factor-beta up-regulates CIM0-engaged IL-12 production of mouse Langerhans cells. Eur J Immunol, 2001, 31 ( 1 ) :294-300.
  • 7Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in muhifocal inflammatory disease. Nature, 1992, 359 (6397) : 693-699.
  • 8McCartney-Francis NL, Wahl SM. Dysregulation of IFNgamma signaling pathways in the absence of TGF-beta 1. J Immunol, 2002,169(10) :5941- 5947.
  • 9Christ M, McCartney-Francis NL, Kulkarni AB, et al. Immune dysregulation in TGF-beta 1- deficient mice. J Immunol, 1994, 153(5) :1936- 1946.
  • 10Sakaguchi S. Regulatory T cells:key controllers of immunologic self-tolerance. Cell, 2000, 101 (5) :455-458.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部